Tuberculosis biomarker and surrogate endpoint research roadmap

Payam Nahid, Jussi Saukkonen, William R. Mac Kenzie, John L. Johnson, Patrick P J Phillips, Janet Andersen, Erin Bliven-Sizemore, John T. Belisle, W. Henry Boom, Annie Luetkemeyer, Thomas B. Campbell, Kathleen D. Eisenach, Richard Hafner, Jeffrey L. Lennox, Mamodikoe Makhene, Susan Swindells, M. Elsa Villarino, Marc Weiner, Constance Benson, William Burman

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The Centers for Disease Control and Prevention and National Institutes of Health convened a multidisciplinary meeting to discuss surrogate markers of treatment response in tuberculosis. The goals were to assess recent surrogate marker research and to provide specific recommendations for (1) the qualification and validation of biomarkers of treatment outcome; (2) the standardization of specimen and data collection for future clinical trials, including a minimum set of samples and collection time points; and (3) the creation of a specimen repository to support biomarker testing. This article summarizes these recommendations and provides a roadmap for their implementation.

Original languageEnglish (US)
Pages (from-to)972-979
Number of pages8
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume184
Issue number8
DOIs
StatePublished - Oct 15 2011

Fingerprint

Tuberculosis
Biomarkers
Research
Specimen Handling
National Institutes of Health (U.S.)
Centers for Disease Control and Prevention (U.S.)
Clinical Trials

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Nahid, P., Saukkonen, J., Mac Kenzie, W. R., Johnson, J. L., Phillips, P. P. J., Andersen, J., ... Burman, W. (2011). Tuberculosis biomarker and surrogate endpoint research roadmap. American Journal of Respiratory and Critical Care Medicine, 184(8), 972-979. https://doi.org/10.1164/rccm.201105-0827WS

Tuberculosis biomarker and surrogate endpoint research roadmap. / Nahid, Payam; Saukkonen, Jussi; Mac Kenzie, William R.; Johnson, John L.; Phillips, Patrick P J; Andersen, Janet; Bliven-Sizemore, Erin; Belisle, John T.; Boom, W. Henry; Luetkemeyer, Annie; Campbell, Thomas B.; Eisenach, Kathleen D.; Hafner, Richard; Lennox, Jeffrey L.; Makhene, Mamodikoe; Swindells, Susan; Villarino, M. Elsa; Weiner, Marc; Benson, Constance; Burman, William.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 184, No. 8, 15.10.2011, p. 972-979.

Research output: Contribution to journalArticle

Nahid, P, Saukkonen, J, Mac Kenzie, WR, Johnson, JL, Phillips, PPJ, Andersen, J, Bliven-Sizemore, E, Belisle, JT, Boom, WH, Luetkemeyer, A, Campbell, TB, Eisenach, KD, Hafner, R, Lennox, JL, Makhene, M, Swindells, S, Villarino, ME, Weiner, M, Benson, C & Burman, W 2011, 'Tuberculosis biomarker and surrogate endpoint research roadmap', American Journal of Respiratory and Critical Care Medicine, vol. 184, no. 8, pp. 972-979. https://doi.org/10.1164/rccm.201105-0827WS
Nahid P, Saukkonen J, Mac Kenzie WR, Johnson JL, Phillips PPJ, Andersen J et al. Tuberculosis biomarker and surrogate endpoint research roadmap. American Journal of Respiratory and Critical Care Medicine. 2011 Oct 15;184(8):972-979. https://doi.org/10.1164/rccm.201105-0827WS
Nahid, Payam ; Saukkonen, Jussi ; Mac Kenzie, William R. ; Johnson, John L. ; Phillips, Patrick P J ; Andersen, Janet ; Bliven-Sizemore, Erin ; Belisle, John T. ; Boom, W. Henry ; Luetkemeyer, Annie ; Campbell, Thomas B. ; Eisenach, Kathleen D. ; Hafner, Richard ; Lennox, Jeffrey L. ; Makhene, Mamodikoe ; Swindells, Susan ; Villarino, M. Elsa ; Weiner, Marc ; Benson, Constance ; Burman, William. / Tuberculosis biomarker and surrogate endpoint research roadmap. In: American Journal of Respiratory and Critical Care Medicine. 2011 ; Vol. 184, No. 8. pp. 972-979.
@article{c81b1fe96d074fc68ed5f69d38be7902,
title = "Tuberculosis biomarker and surrogate endpoint research roadmap",
abstract = "The Centers for Disease Control and Prevention and National Institutes of Health convened a multidisciplinary meeting to discuss surrogate markers of treatment response in tuberculosis. The goals were to assess recent surrogate marker research and to provide specific recommendations for (1) the qualification and validation of biomarkers of treatment outcome; (2) the standardization of specimen and data collection for future clinical trials, including a minimum set of samples and collection time points; and (3) the creation of a specimen repository to support biomarker testing. This article summarizes these recommendations and provides a roadmap for their implementation.",
author = "Payam Nahid and Jussi Saukkonen and {Mac Kenzie}, {William R.} and Johnson, {John L.} and Phillips, {Patrick P J} and Janet Andersen and Erin Bliven-Sizemore and Belisle, {John T.} and Boom, {W. Henry} and Annie Luetkemeyer and Campbell, {Thomas B.} and Eisenach, {Kathleen D.} and Richard Hafner and Lennox, {Jeffrey L.} and Mamodikoe Makhene and Susan Swindells and Villarino, {M. Elsa} and Marc Weiner and Constance Benson and William Burman",
year = "2011",
month = "10",
day = "15",
doi = "10.1164/rccm.201105-0827WS",
language = "English (US)",
volume = "184",
pages = "972--979",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "8",

}

TY - JOUR

T1 - Tuberculosis biomarker and surrogate endpoint research roadmap

AU - Nahid, Payam

AU - Saukkonen, Jussi

AU - Mac Kenzie, William R.

AU - Johnson, John L.

AU - Phillips, Patrick P J

AU - Andersen, Janet

AU - Bliven-Sizemore, Erin

AU - Belisle, John T.

AU - Boom, W. Henry

AU - Luetkemeyer, Annie

AU - Campbell, Thomas B.

AU - Eisenach, Kathleen D.

AU - Hafner, Richard

AU - Lennox, Jeffrey L.

AU - Makhene, Mamodikoe

AU - Swindells, Susan

AU - Villarino, M. Elsa

AU - Weiner, Marc

AU - Benson, Constance

AU - Burman, William

PY - 2011/10/15

Y1 - 2011/10/15

N2 - The Centers for Disease Control and Prevention and National Institutes of Health convened a multidisciplinary meeting to discuss surrogate markers of treatment response in tuberculosis. The goals were to assess recent surrogate marker research and to provide specific recommendations for (1) the qualification and validation of biomarkers of treatment outcome; (2) the standardization of specimen and data collection for future clinical trials, including a minimum set of samples and collection time points; and (3) the creation of a specimen repository to support biomarker testing. This article summarizes these recommendations and provides a roadmap for their implementation.

AB - The Centers for Disease Control and Prevention and National Institutes of Health convened a multidisciplinary meeting to discuss surrogate markers of treatment response in tuberculosis. The goals were to assess recent surrogate marker research and to provide specific recommendations for (1) the qualification and validation of biomarkers of treatment outcome; (2) the standardization of specimen and data collection for future clinical trials, including a minimum set of samples and collection time points; and (3) the creation of a specimen repository to support biomarker testing. This article summarizes these recommendations and provides a roadmap for their implementation.

UR - http://www.scopus.com/inward/record.url?scp=80054693304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054693304&partnerID=8YFLogxK

U2 - 10.1164/rccm.201105-0827WS

DO - 10.1164/rccm.201105-0827WS

M3 - Article

VL - 184

SP - 972

EP - 979

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 8

ER -